Heikki Lanckriet
Vorstandsvorsitzender bei 4BASEBIO PLC
Vermögen: 19 Mio $ am 30.04.2024
Profil
Heikki Lanckriet is the founder of Expedeon Ltd.
(founded in 2003) and Expedeon Holdings Ltd.
(founded in 2003).
He is currently the CEO, Executive Director & Chief Scientific Officer at 4basebio Plc (since 2020) and holds various director positions at NeoPhore Ltd., Kither Biotech Srl, 4basebio Slu, 4basebio UK Ltd., Biofrontera, Inc., Heqet Therapeutics SRL, 4basebio Discovery Ltd., and I2i Capital Ltd.
He is also a Member-Supervisory Board at Biofrontera AG (since 2021).
Previously, he served as the Chief Executive Officer & Chief Scientific Officer at 2invest AG (2016-2020) and as an Independent Member-Supervisory Board at Epigenomics AG (2022-2024).
Dr. Lanckriet has also worked at Puratos NV and the University of Cambridge.
He holds a doctorate degree from the University of Cambridge and undergraduate and graduate degrees from Ghent University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
4BASEBIO PLC
11,08% | 07.02.2024 | 1 418 994 ( 11,08% ) | 19 Mio $ | 30.04.2024 |
Aktive Positionen von Heikki Lanckriet
| Unternehmen | Position | Beginn |
|---|---|---|
| 4BASEBIO PLC | Vorstandsvorsitzender | 22.12.2020 |
| BIOFRONTERA AG | Direktor/Vorstandsmitglied | 14.12.2021 |
| BIOFRONTERA INC. | Direktor/Vorstandsmitglied | 12.07.2023 |
Expedeon Ltd.
 Expedeon Ltd. BiotechnologyHealth Technology Expedeon Ltd. develops and produces proteins for drug discovery. Its products include gel electrophoresis, nucleic acid kits, protein quantitation, western blotting reagents and spectroscopy. The firm provides genomics and proteomics tools to scientists. The company was founded by Heikki Lanckriet in 2003 and is headquartered in Cambridge, the United Kingdom. | Vorstandsvorsitzender | 07.01.2010 |
Heqet Therapeutics SRL
 Heqet Therapeutics SRL Pharmaceuticals: MajorHealth Technology Heqet Therapeutics SRL is an Italian biotechnology company that specializes in cardiac regenerative medicine. The company is based in Turin, Italy. The company was founded by Mauro Giacca. Marta Antonucci has been the CEO of the company since 2022. | Direktor/Vorstandsmitglied | - |
| I2i Capital Ltd. | Direktor/Vorstandsmitglied | - |
NeoPhore Ltd.
 NeoPhore Ltd. Miscellaneous Commercial ServicesCommercial Services NeoPhore Ltd. engages in discovery and development of small molecules inhibitors to treat cancer. The company is headquartered in Kings Cross, London, the United Kingdom. | Direktor/Vorstandsmitglied | - |
| 4basebio Slu | Direktor/Vorstandsmitglied | - |
| 4basebio Discovery Ltd. | Direktor/Vorstandsmitglied | - |
| ░░░░░░ ░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ehemalige bekannte Positionen von Heikki Lanckriet
| Unternehmen | Position | Ende |
|---|---|---|
| ░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░░░░ ░░ ░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Heikki Lanckriet
| Ghent University | Graduate Degree |
| University of Cambridge | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 5 |
|---|---|
| 4BASEBIO PLC | Health Technology |
| 2INVEST AG | Finance |
| BIOFRONTERA AG | Health Technology |
| EPIGENOMICS AG | Health Technology |
| BIOFRONTERA INC. | Health Technology |
| Private Unternehmen | 10 |
|---|---|
Expedeon Ltd.
Expedeon Ltd. BiotechnologyHealth Technology Expedeon Ltd. develops and produces proteins for drug discovery. Its products include gel electrophoresis, nucleic acid kits, protein quantitation, western blotting reagents and spectroscopy. The firm provides genomics and proteomics tools to scientists. The company was founded by Heikki Lanckriet in 2003 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Puratos NV
 Puratos NV Food: Specialty/CandyConsumer Non-Durables Puratos NV manufactures and supplies ingredients to the bakery, patisserie, and chocolate sectors. Its products include specialty bread mixes, emulsifiers, yeast, cakes, fruit and cream fillings, chocolate and nut fillings, and decoration solutions. The firm also offers recipes, flavoring preparations, glazes, icing, fudge, ganache and non-dairy toppings. The company was founded on September 28, 1989 and is headquartered in Groot-Bijgaarden, Belgium. | Consumer Non-Durables |
Expedeon Holdings Ltd.
 Expedeon Holdings Ltd. BiotechnologyHealth Technology Expedeon Holdings Ltd. develops, manufactures, and commercializes proteomics reagents and tools. The company was founded on January 7, 2009 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
4basebio UK Ltd.
 4basebio UK Ltd. Wholesale DistributorsDistribution Services 4basebio Ltd. engages in the genomics and DNA manufacturing business. The company was founded on November 5, 2019 and is headquartered in Cambridge, the United Kingdom. | Distribution Services |
Kither Biotech Srl
 Kither Biotech Srl Pharmaceuticals: MajorHealth Technology Kither Biotech Srl is a biotechnology company, which engages in the research and development of pharmaceutical products. It focuses on the treatment of chronic inflammatory diseases. The company was founded by Emilio Hirsch, Marco Kevin Malisani, and Alberto Bardelli and is headquartered in Turin, Italy. | Health Technology |
| 4basebio Discovery Ltd. | |
| 4basebio Slu | |
NeoPhore Ltd.
NeoPhore Ltd. Miscellaneous Commercial ServicesCommercial Services NeoPhore Ltd. engages in discovery and development of small molecules inhibitors to treat cancer. The company is headquartered in Kings Cross, London, the United Kingdom. | Commercial Services |
| I2i Capital Ltd. | |
Heqet Therapeutics SRL
Heqet Therapeutics SRL Pharmaceuticals: MajorHealth Technology Heqet Therapeutics SRL is an Italian biotechnology company that specializes in cardiac regenerative medicine. The company is based in Turin, Italy. The company was founded by Mauro Giacca. Marta Antonucci has been the CEO of the company since 2022. | Health Technology |
